|
CLCN6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.290800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.956600E-01 |
| Normal-vs-Stage2 |
4.250200E-01 |
| Normal-vs-Stage3 |
1.917790E-01 |
| Normal-vs-Stage4 |
3.082100E-03 |
| Stage1-vs-Stage2 |
2.461800E-01 |
| Stage1-vs-Stage3 |
2.875600E-01 |
| Stage1-vs-Stage4 |
5.740000E-02 |
| Stage2-vs-Stage3 |
1.087990E-01 |
| Stage2-vs-Stage4 |
1.193830E-02 |
| Stage3-vs-Stage4 |
2.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.030800E-01 |
| Normal-vs-AfricanAmerican |
3.933200E-01 |
| Normal-vs-Asian |
2.720200E-03 |
| Caucasian-vs-AfricanAmerican |
2.644000E-01 |
| Caucasian-vs-Asian |
4.504300E-02 |
| AfricanAmerican-vs-Asian |
7.947700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.792200E-01 |
| Normal-vs-Female |
5.708000E-01 |
| Male-vs-Female |
3.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.258600E-01 |
| Normal-vs-Extreme_Weight |
2.703600E-01 |
| Normal-vs-Obese |
8.014800E-01 |
| Normal-vs-Extreme_Obese |
9.246400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.932000E-01 |
| Normal_Weight-vs-Obese |
6.089000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.089800E-01 |
| Extreme_Weight-vs-Obese |
2.314400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.395600E-01 |
| Obese-vs-Extreme_Obese |
9.064200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.235800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.767400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.453800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.230400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.873980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.322400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.837400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.731600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.214400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.861200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.968600E-01 |
| Normal-VS-Type2 PRCC |
4.644600E-01 |
| Normal-VS-KIRP CIMP |
2.385100E-04 |
| Normal-VS-Unclassified PRCC |
2.353800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.230000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.459000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.038400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.664300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.104400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.833840E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.769000E-01 |
| Normal-vs-N1 |
1.033630E-01 |
| Normal-vs-N2 |
1.114280E-02 |
| N0-vs-N1 |
2.591800E-01 |
| N0-vs-N2 |
1.576420E-01 |
| N1-vs-N2 |
3.882200E-01 |
|
|
